Health Care • Industrial Specialties
$0.32 ▼ +0.00
(-0.54%)
MKT CAP: $28.6M • VOL: 263.5K
52W L $0 52W H $1
ROARABLE / RQD
D- • 43/100
PIOTROSKI
4 / 9
MLSS // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $9.0M | $8.6M | $0 |
| YoY Revenue Growth % | — | — | — |
| Gross Profit | $6.4M | $6.4M | — |
| Gross Margin % | 71.4% | 74.6% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$5.7M | -$6.8M | -$7.1M |
| Operating Margin % | -63.5% | -78.3% | — |
| Net Income (GAAP) | $5.7M | $4.7M | $6.9M |
| EBITDA (Normalized) | -$5.7M | -$6.7M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$2.9M | -$2.9M | -$5.3M |
| Capital Expenditures (CapEx) | $15.1K | $10.1K | — |
| Free Cash Flow (FCF) | -$2.9M | -$2.9M | -$5.3M |
| FCF Margin % | -32.7% | -34.0% | — |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $1.1M | $3.3M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $2.8M | $5.8M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR MLSS.